2 reports

  • Asthma Therapeutics Market, Global, All Pipeline Products, Phase I, 2016
  • Asthma Therapeutics Market, Global, All Pipeline Products, Phase III, 2016

Asthma Therapeutics in Asia-Pacific Markets to 2023 - High Prevalence and Highly Priced Existing & Upcoming Biologics will Drive the Market Summary Asthma is a common chronic inflammatory disease of the airways. It is characterized by recurrent attacks of breathlessness and wheezing that vary in frequency and severity...

  • Asthma
  • Clinical Trial
  • Monoclonal Antibody
  • Therapy
  • Teva Pharmaceutical Industries Ltd.
  • DEC 09, 2016: ADHERIUM'S SMARTINHALER TECHNOLOGY CHOSEN FOR MAJOR ASTHMA INITIATIVE
  • NOV 17, 2016: INDEPENDENT CLINICAL STUDY SHOWS ADHERIUM'S SMARTINHALER DRAMATICALLY IMPROVES CLINICAL OUTCOMES AND MEDICATION ADHERENCE IN CHILDREN WITH ASTHMA

Summary Teva Pharmaceutical Industries Ltd (Teva) is a pharmaceutical company that carries out the research, development, manufacture and commercialization of generics, branded pharmaceuticals and active pharmaceutical ingredients (APIs). It offers chemical and generic medicines in various forms such as capsules, tablets, ointments,...

  • Asthma
  • United States
  • Company Financials
  • Market Size
  • Teva Pharmaceutical Industries Ltd.